Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Adverse Cardiac-cerebral-kidney Event”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Large-scale testing (Phase 3)Looking for participantsNCT07241390
What this trial is testing

Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

Who this might be right for
Atherosclerosis Cardiovascular DiseaseChronic Kidney Disease
Eli Lilly and Company 7,140
Not applicableStudy completedNCT02533128
What this trial is testing

Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery

Who this might be right for
HypotensionPostoperative ComplicationsAcute Coronary Syndrome+6 more
Miodrag Filipovic, Prof. Dr. med. 458
Not applicableStudy completedNCT03185598
What this trial is testing

MACE and First Operating Room Systolic Blood Pressure in Patients Undergoing Non-cardiac Surgery Implications for the Hypertension Threshold

Who this might be right for
Major Adverse Cardiac-cerebral-kidney Event
Peking University First Hospital 90,342
Large-scale testing (Phase 3)Active Not RecruitingNCT06383390
What this trial is testing

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)
Eli Lilly and Company 10,000